COVID-19 Workplace Testing Study: Phase II Analysis.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 41235907.
- Also identified by DOI 10.1097/JOM.0000000000003613.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
US businesses were considerably impacted by the COVID-19 pandemic. Return to work after exposure or illness was challenging. This study aimed to assess employers' experiences and perspectives during the pandemic with SARS-CoV-2 testing in their workforce. An anonymous survey was delivered to employers across nine NORA sectors. Data were analyzed using SAS Version 9.4. Thirty percent of the respondents worked in a small-sized company (<100 employees), 28% were 100-500 employees, and 42% were more than 500. Small, medium, and large companies were differentially affected, with larger companies affected the most. Sixty-eight percent reported utilizing testing in their return-to-work strategy. Delay in getting results was the most common reported barrier to testing during the early phase of the pandemic (60%). This study will help prepare employers in return-to-work testing decisions in future pandemics.
Medical subject headings
- COVID-19
- Return to Work
- Workplace
- COVID-19 Testing